A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Combination of Melphalan, Prednisone, and 50 mg Thalidomide Treatment in Non-Transplant-Candidate Patients with Newly Diagnosed Multiple Myeloma

Published:2011 Issue:4 Volume:26 Page:403
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Chang Hye Jung¹,Lee Jae Hoon²,Do Young Rok³,Bae Sung-Hwa⁴,Lee Jung-Lim⁵,Nam Seung Hyun⁶,Yoon Sung-Soo⁷,Bang Soo-Mee¹

Affiliation:

1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

2. Department of Internal Medicine, Gachon University Gil Hospital, Incheon, Korea.

3. Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.

4. Department of Internal Medicine, Catholic University of Daegu, Daegu, Korea.

5. Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea.

6. Department of Internal Medicine, Seoul Veterans Hospital, Seoul, Korea.

7. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

Publisher

Korean Association of Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.3904/kjim.2011.26.4.403

Reference21 articles.

1. Multiple Myeloma

2. A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK

3. Multiple Myeloma in Korea -Clinical analysis and treatment results in 61 cases-

4. Epidemiological Change of Multiple Myeloma in Korea

5. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies;JAMA Oncology;2017-07-01

2. Is the Low-Thalidomide Dose MPT Regimen Beneficial?;The Korean Journal of Internal Medicine;2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3